Latest Insider Transactions at Ceridian Hcm Holding Inc. (CDAY)
This section provides a real-time view of insider transactions for Ceridian Hcm Holding Inc. (CDAY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ceridian HCM Holding Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ceridian HCM Holding Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 03
2023
|
Christopher R Armstrong EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,917
-3.97%
|
$319,605
$65.77 P/Share
|
Jun 30
2023
|
Noemie Clemence Heuland EVP, CFO |
SELL
Open market or private sale
|
Direct |
4,200
-5.66%
|
$277,200
$66.47 P/Share
|
Jun 09
2023
|
Samer Alkharrat EVP, Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,814
+50.0%
|
-
|
Jun 07
2023
|
Leagh Erin Turner Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,000
-2.39%
|
$396,000
$66.26 P/Share
|
Jun 07
2023
|
Leagh Erin Turner Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+2.33%
|
$294,000
$49.93 P/Share
|
May 17
2023
|
Leagh Erin Turner Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,000
-2.78%
|
$420,000
$60.0 P/Share
|
May 17
2023
|
Leagh Erin Turner Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+2.7%
|
$266,000
$38.63 P/Share
|
May 15
2023
|
Linda Provie Mantia Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,025
+23.77%
|
-
|
May 15
2023
|
Andrea Rosen Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,187
+29.9%
|
-
|
May 15
2023
|
Gerald C Throop Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,187
+18.19%
|
-
|
May 15
2023
|
Ronald Clarke Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,187
+13.3%
|
-
|
May 15
2023
|
Deborah A Farrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,187
+18.16%
|
-
|
May 15
2023
|
Brent B Bickett Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,234
+28.67%
|
-
|
May 15
2023
|
Gnaneshwar B. Rao Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,025
+8.62%
|
-
|
May 15
2023
|
Thomas M Hagerty Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,150
+5.12%
|
-
|
May 09
2023
|
William Everett Mc Donald EVP, CLO, & Secretary |
SELL
Open market or private sale
|
Direct |
709
-1.3%
|
$40,413
$57.82 P/Share
|
May 09
2023
|
Christopher R Armstrong EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,772
-1.41%
|
$101,004
$57.82 P/Share
|
May 09
2023
|
Jeffrey Scott Jacobs Head of Acct & Fin Reporting |
SELL
Open market or private sale
|
Direct |
159
-0.83%
|
$9,063
$57.82 P/Share
|
Apr 06
2023
|
Leagh Erin Turner Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,000
-2.39%
|
$408,000
$68.11 P/Share
|
Apr 06
2023
|
Leagh Erin Turner Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+2.33%
|
$228,000
$38.63 P/Share
|
Mar 09
2023
|
William Everett Mc Donald EVP, CLO, & Secretary |
SELL
Open market or private sale
|
Direct |
1,159
-1.07%
|
$82,289
$71.69 P/Share
|
Mar 09
2023
|
Joseph B Korngiebel EVP, CSPTO |
SELL
Open market or private sale
|
Direct |
6,188
-2.36%
|
$439,348
$71.69 P/Share
|
Mar 09
2023
|
Jeffrey Scott Jacobs Head of Acct & Fin Reporting |
SELL
Open market or private sale
|
Direct |
510
-1.34%
|
$36,210
$71.69 P/Share
|
Mar 09
2023
|
Stephen H. Holdridge President, COO |
SELL
Open market or private sale
|
Direct |
2,814
-1.93%
|
$199,794
$71.69 P/Share
|
Mar 09
2023
|
Christopher R Armstrong EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,690
-2.25%
|
$403,990
$71.69 P/Share
|
Mar 08
2023
|
William Everett Mc Donald EVP, CLO, & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,544
+2.74%
|
-
|
Mar 08
2023
|
Joseph B Korngiebel EVP, CSPTO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,176
+4.45%
|
-
|
Mar 08
2023
|
Jeffrey Scott Jacobs Head of Acct & Fin Reporting |
BUY
Exercise of conversion of derivative security
|
Direct |
823
+4.09%
|
-
|
Mar 08
2023
|
Stephen H. Holdridge President, COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,088
+4.03%
|
-
|
Mar 08
2023
|
Christopher R Armstrong EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,176
+4.59%
|
-
|
Mar 07
2023
|
Leagh Erin Turner Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,000
-1.2%
|
$450,000
$75.08 P/Share
|
Mar 07
2023
|
Leagh Erin Turner Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+2.33%
|
$228,000
$38.63 P/Share
|
Mar 01
2023
|
William Everett Mc Donald EVP, CLO, & Secretary |
SELL
Open market or private sale
|
Direct |
44
-0.08%
|
$3,168
$72.86 P/Share
|
Mar 01
2023
|
Jeffrey Scott Jacobs Head of Acct & Fin Reporting |
SELL
Open market or private sale
|
Direct |
24
-0.13%
|
$1,728
$72.86 P/Share
|
Mar 01
2023
|
Christopher R Armstrong EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
236
-0.19%
|
$16,992
$72.86 P/Share
|
Feb 28
2023
|
David D Ossip Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
68,558
+9.01%
|
-
|
Feb 28
2023
|
Leagh Erin Turner Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
68,558
+21.85%
|
-
|
Feb 28
2023
|
Joseph B Korngiebel EVP, CSPTO |
BUY
Grant, award, or other acquisition
|
Direct |
27,423
+17.46%
|
-
|
Feb 28
2023
|
William Everett Mc Donald EVP, CLO, & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
13,711
+20.32%
|
-
|
Feb 28
2023
|
Stephen H. Holdridge President, COO |
BUY
Grant, award, or other acquisition
|
Direct |
27,423
+27.6%
|
-
|
Feb 28
2023
|
Jeffrey Scott Jacobs Head of Acct & Fin Reporting |
BUY
Grant, award, or other acquisition
|
Direct |
8,227
+30.49%
|
-
|
Feb 28
2023
|
Christopher R Armstrong EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,423
+17.95%
|
-
|
Feb 28
2023
|
Noemie Clemence Heuland EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
17,139
+18.75%
|
-
|
Feb 27
2023
|
Rakesh Subramanian EVP, Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
3,692
-1.96%
|
$265,824
$72.44 P/Share
|
Feb 27
2023
|
William Everett Mc Donald EVP, CLO, & Secretary |
SELL
Open market or private sale
|
Direct |
3,157
-2.69%
|
$227,304
$72.44 P/Share
|
Feb 27
2023
|
Joseph B Korngiebel EVP, CSPTO |
SELL
Open market or private sale
|
Direct |
5,589
-1.84%
|
$402,408
$72.44 P/Share
|
Feb 27
2023
|
Jeffrey Scott Jacobs Head of Acct & Fin Reporting |
SELL
Open market or private sale
|
Direct |
1,055
-3.45%
|
$75,960
$72.44 P/Share
|
Feb 27
2023
|
Noemie Clemence Heuland EVP, CFO |
SELL
Open market or private sale
|
Direct |
3,211
-1.94%
|
$231,192
$72.44 P/Share
|
Feb 27
2023
|
Stephen H. Holdridge President, COO |
SELL
Open market or private sale
|
Direct |
4,734
-3.64%
|
$340,848
$72.44 P/Share
|
Feb 27
2023
|
Christopher R Armstrong EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,871
-2.34%
|
$494,712
$72.44 P/Share
|